SCHEMBL5222918

SCHEMBL5222918

C[C@H](NC[C@H](O)[C@H](Cc1ccccc1)NC(=O)c1cc(NCS(C)(=O)=O)cc(N2CCCC2=O)c1)C(=O)NC1CCCCC1

nearest known ligand 0.86

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CTSD P07339 20/20 0.86
BACE1 P56817 20/20 0.86
BACE2 Q9Y5Z0 20/20 0.86

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5222911 1.00 CTSD (0.86) CTSDBACE1BACE2
SCHEMBL5221252 0.93 CTSD (0.85) CTSDBACE1BACE2
SCHEMBL5220317 0.93 CTSD (0.85) CTSDBACE1BACE2
SCHEMBL5220140 0.93 CTSD (0.90) CTSDBACE1BACE2
SCHEMBL5220148 0.93 CTSD (0.90) CTSDBACE1BACE2
SCHEMBL5223469 0.93 CTSD (1.00) CTSDBACE1BACE2
SCHEMBL5217341 0.93 CTSD (1.00) CTSDBACE1BACE2
SCHEMBL5222401 0.93 CTSD (1.00) CTSDBACE1BACE2
SCHEMBL5217350 0.93 CTSD (1.00) CTSDBACE1BACE2
SCHEMBL5223290 0.92 CTSD (0.82) CTSDBACE1BACE2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567488-B1 HYDROXYETHYLAMINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE GLAXO GROUP LTD (GB) 2007-02-21 EP claimed